Randomized study for treatment of COVID pneumonia uses cystic fibrosis drug dornase alfa

(Boston Children's Hospital) Researchers at Boston Children's Hospital and Brigham and Women's Hospital have launched a randomized, placebo-controlled clinical trial of dornase alfa (Pulmozyme) in patients with severe COVID-19 pneumonia and respiratory failure requiring mechanical ventilation. The study aims to enroll 60 adults and children (over age 3) admitted to intensive care units.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news